✓Strengths
- Low debt: debt-to-equity of 0.13.
- Comfortable interest cover: operating profit covers interest about 441,165.6 times.
- Return on equity is healthy at 57.3%.
- Return on capital employed is healthy at 57.2%.
- Net profit margin is strong at 351.4%.
- Profit has compounded about 406% a year over five years.
!Watch-points
- Sales growth has been slow over five years (about -14% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.64
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 2,514.45
ROCE57.19%
ROE57.28%
Debt to Equity0.13
Current Ratio1.10
EPS₩ 1,440.00
PAT Margin351.35%
ICR441165.56
Compounded Sales Growth
10 Years
—
5 Years
-13.76%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
406.15%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
57.28%